Shanghai Haohai Biological Technology Co., Ltd.

SHSE:688366 Rapport sur les actions

Capitalisation boursière : CN¥13.7b

Shanghai Haohai Biological Technology Croissance future

Future contrôle des critères 1/6

Shanghai Haohai Biological Technology is forecast to grow earnings and revenue by 18.6% and 12.5% per annum respectively. EPS is expected to grow by 21.3% per annum. Return on equity is forecast to be 10.3% in 3 years.

Informations clés

18.6%

Taux de croissance des bénéfices

21.3%

Taux de croissance du BPA

Biotechs croissance des bénéfices44.8%
Taux de croissance des recettes12.5%
Rendement futur des capitaux propres10.3%
Couverture par les analystes

Low

Dernière mise à jour26 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Prévisions de croissance des bénéfices et des revenus

SHSE:688366 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20263,650684N/AN/A1
12/31/20253,315605N/AN/A1
12/31/20242,907515N/AN/A1
9/30/20242,747430325674N/A
6/30/20242,746446296679N/A
3/31/20242,689432239630N/A
12/31/20232,654416367634N/A
9/30/20232,53034699442N/A
6/30/20232,48731592401N/A
3/31/20232,263226-35254N/A
12/31/20222,130180-86231N/A
9/30/20222,06320352343N/A
6/30/20221,86119257336N/A
3/31/20221,80527264339N/A
12/31/20211,75035270342N/A
9/30/20211,702428115333N/A
6/30/20211,674434120342N/A
3/31/20211,594370N/AN/AN/A
12/31/20201,32423066262N/A
9/30/20201,343232-20258N/A
6/30/20201,3062166258N/A
3/31/20201,437279N/AN/AN/A
12/31/20191,595371-50349N/A
9/30/20191,537353-8286N/A
6/30/20191,570386-7302N/A
3/31/20191,478375N/AN/AN/A
12/31/20181,546415239391N/A
9/30/20181,523411235398N/A
6/30/20181,501408N/A404N/A
3/31/20181,423390N/A374N/A
12/31/20171,345372N/A343N/A
9/30/20171,214351N/A330N/A
6/30/20171,083329N/A317N/A
3/31/2017967317N/A286N/A
12/31/2016851305N/A254N/A
9/30/2016787295N/A245N/A
6/30/2016724284N/A235N/A
3/31/2016694279N/A252N/A
12/31/2015664273N/A269N/A
9/30/2015630258N/A244N/A
6/30/2015597243N/A219N/A
3/31/2015556213N/A181N/A
12/31/2014516184N/A142N/A
9/30/2014482169N/A135N/A
6/30/2014449154N/A128N/A
3/31/2014425148N/A137N/A
12/31/2013401142N/A147N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: 688366's forecast earnings growth (18.6% per year) is above the savings rate (2.9%).

Bénéfices vs marché: 688366's earnings (18.6% per year) are forecast to grow slower than the CN market (25.8% per year).

Croissance élevée des bénéfices: 688366's earnings are forecast to grow, but not significantly.

Chiffre d'affaires vs marché: 688366's revenue (12.5% per year) is forecast to grow slower than the CN market (14% per year).

Croissance élevée des revenus: 688366's revenue (12.5% per year) is forecast to grow slower than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: 688366's Return on Equity is forecast to be low in 3 years time (10.3%).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y